Trademarkia Logo

Canada

C$
BLOCK IGE UNLOCK LIFE
REGISTERED

on 21 Sept 2022

Last Applicant/ Owned by

NOVARTIS AG

CH-4002 Basel

CH

Serial Number

2028172 filed on 27th Mar 2020

Registration Number

TMA1142699 registered on 21st Sept 2022

Registration expiry Date

27th Mar 2030

Correspondent Address

SMART & BIGGAR LP

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

CA

M5H3Y2

BLOCK IGE UNLOCK LIFE

Trademark usage description

pharmaceutical preparations for the prevention and treatment of the central nervous system, namely, central nervous system infections, brain diseases, Read More

Vienna Information


26 . 3 . 23

Lines or bands forming an angle -- Note: Including chevrons and arrowheads formed by lines or bands.Lignes ou bandes formant un angle -- Note: Y compris les chevrons et les pointes de flèches formées par des lignes ou des bandes.

26 . 4 . 2

RectanglesRectangles

26 . 4 . 5

One quadrilateralUn quadrilatère

26 . 4 . 11

Quadrilaterals containing one or more triangles or lines forming an angleQuadrilatères contenant un ou plusieurs triangles ou des lignes formant un angle

26 . 4 . 18

Quadrilaterals containing one or more lettersQuadrilatères contenant une ou plusieurs lettres

26 . 4 . 24

Quadrilaterals with dark surfaces or parts of surfacesQuadrilatères avec surface ou partie de la surface foncée

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 11

Letters underlined, overlined, framed or barred by one or more strokesLettres soulignées, surlignées, encadrées ou barrées d'un ou de plusieurs traits

29 . 1 . 5

VioletViolet

29 . 1 . 6

White, grey, silverBlanc, gris, argent

Classification Information


Class [005]
Pharmaceutical preparations for the prevention and treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the prevention and treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; antiinflammatories; pharmaceutical preparations for the prevention and treatment of disorders of the respiratory system; pharmaceutical preparations for the prevention and treatment of disorders of the musculo-skeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the prevention and treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in hematology, namely for the treatment of blood disorders; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for prevention and treatment of ocular disorders and diseases; anti-infectives, antibacterials, antivirals, antibiotics, systemic and topical antifungals


Classification kind code

11

Class [044]
Medical services, namely providing healthcare information, in particular, pharmaceuticals via a website


Classification kind code

11

Mark Details


Serial Number

2028172

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 48
on 18th Mar 2022
Agent Changed
Submitted for opposition 22
on 14th May 2021
Search Recorded
Submitted for opposition 20
on 14th May 2021
Examiner's First Report
Submitted for opposition 223
on 14th May 2021
Total Provisional Refusal
Submitted for opposition 256
on 15th Mar 2021
Notification of Possible Opposition Sent
Submitted for opposition 257
on 14th May 2020
Designation Notification - Madrid Protocol
Submitted for opposition 31
on 13th May 2020
Formalized
Submitted for opposition 1
on 13th May 2020
Created
Submitted for opposition 228
on 27th Mar 2020
International Registration
Submitted for opposition 30
on 27th Mar 2020
Filed